Cassie Jung, Chief Operating Officer at Aquestive Therapeutics, Inc. (AQST), sold 135,150 shares at $7.01 ($947K) on 2025-10-15, disclosed to the SEC on 2025-10-17.
Scheduled sale ($947k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.01 | 67,575 | $474K | 50.0% |
| 2 | $7.01 | 67,575 | $474K | 50.0% |
| Total | $7.01 avg | 135,150 | $947K | 100% |
| Filing → |
| AQST | SELL | 2024-11-27 | $214 | — | Filing → |